189 related articles for article (PubMed ID: 3968642)
1. Cardiovascular effects of losulazine hydrochloride, a peripheral norepinephrine-depleting agent, in nonhuman primates.
Pals DT; DeGraaf GL
J Pharmacol Exp Ther; 1985 Feb; 232(2):407-12. PubMed ID: 3968642
[TBL] [Abstract][Full Text] [Related]
2. Hormonal and cardiovascular effects of losulazine hydrochloride in relation to sodium balance in nonhuman primates.
Pals DT
Clin Exp Hypertens A; 1986; 8(7):1179-88. PubMed ID: 3533328
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of losulazine and reserpine on central aminergic neurons.
Pan JT; Hooth MJ; Lookingland KJ; Moore KE; Marks TA
Toxicol Appl Pharmacol; 1993 Nov; 123(1):26-33. PubMed ID: 8236258
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of cocaine in conscious rats: relative significance of central sympathetic stimulation and peripheral neuronal monoamine uptake and release mechanisms.
Tella SR; Schindler CW; Goldberg SR
J Pharmacol Exp Ther; 1992 Aug; 262(2):602-10. PubMed ID: 1501115
[TBL] [Abstract][Full Text] [Related]
5. U-54,669F: a novel hypotensive agent.
Wendling MG; DuCharme DW; Johnson GA; McCall RB; Pals DT
Fed Proc; 1983 Feb; 42(2):162-6. PubMed ID: 6822289
[TBL] [Abstract][Full Text] [Related]
6. Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man.
Mitchell JR; Cavanaugh JH; Arias L; Oates JA
J Clin Invest; 1970 Aug; 49(8):1596-604. PubMed ID: 5431666
[TBL] [Abstract][Full Text] [Related]
7. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the hypotensive action of prazosin.
Constantine JW; McShane WK; Scriabine A; Hess HJ
Postgrad Med; 1975 Nov; Spec No():18-35. PubMed ID: 1197141
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action.
Lenke D; Gries J; Kretzschmar R
Arzneimittelforschung; 1981; 31(9a):1558-65. PubMed ID: 7197970
[TBL] [Abstract][Full Text] [Related]
11. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and antihypertensive actions of 1-methyl-3-keto-4-phenylquinuclidinium bromide.
Vidrio H; Hong E
Arzneimittelforschung; 1976; 26(9):1662-5. PubMed ID: 1036695
[TBL] [Abstract][Full Text] [Related]
13. Novel hypotensive agents from Verbesina caracasana. 6. Synthesis and pharmacology of caracasandiamide.
Carmignani M; Volpe AR; Delle Monache F; Botta B; Espinal R; De Bonnevaux SC; De Luca C; Botta M; Corelli F; Tafi A; Ripanti G; Monache GD
J Med Chem; 1999 Aug; 42(16):3116-25. PubMed ID: 10447956
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic guanethidine administration on cardiovascular function of dogs.
Jandhyala BS; Cavero I; Buckley JP
Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):523-32. PubMed ID: 1179027
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. III. Action on the secretions of the digestive tract and on the central nervous system, acute toxicity.
Cosnier D; Hache J; Labrid C; Streichenberger G
Arzneimittelforschung; 1975; 25(12):1926-33. PubMed ID: 3186
[TBL] [Abstract][Full Text] [Related]
16. [The effect of reserpine, guanethidine and methyldopa on general and regional hemodynamics].
Iuzhakov SD; Kotliarov EV
Farmakol Toksikol; 1973; 26(4):429-32. PubMed ID: 4789888
[No Abstract] [Full Text] [Related]
17. Differential effects of L-NAME on blood pressure and heart rate responses to acetylcholine and bradykinin in cynomolgus primates.
Weldon SM; Winquist RJ; Madwed JB
J Pharmacol Exp Ther; 1995 Jan; 272(1):126-33. PubMed ID: 7529307
[TBL] [Abstract][Full Text] [Related]
18. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
Constantine JW; Lebel W; Weeks R
J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism.
Yalcin M; Aydin C
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):447-53. PubMed ID: 19702598
[TBL] [Abstract][Full Text] [Related]
20. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
Nekooeian AA; Tabrizchi R
Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
